HR Execs on the Move

HealthCheckUSA / EmployeeWellnessUSA

www.healthcheckusa.com

 
HealthCheckUSA / EmployeeWellnessUSA is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

ZRT Laboratories

Not only does ZRT provide you with quality saliva and blood spot testing, we also strive to be eco-friendly and socially responsible. Environmental sustainability is also an abiding concern of ZRT founder, Dr. Zava. All laboratory processes are

Life Care Sleep and Health Center

Life Care Sleep and Health Center is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

phadia

phadia is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Good Start Genetics

Good Start Genetics is an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability combined with other technologies to deliver best-in-class tests for routine genetic screening. Through its GoodStart Select(TM) offering, the company provides the most comprehensive and clinically actionable set of tests for known and novel mutations that cause inherited diseases. Good Start`s NGS capabilities can be applied to multiple disease areas, including pre-conception carrier screening in the in-vitro fertilization setting.

BioTelemetry

The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research. Please visit our subsidiary pages for more information.